tradingkey.logo
tradingkey.logo
Search

Lexeo Therapeutics Inc

LXEO
Add to Watchlist
4.480USD
-0.180-3.86%
Close 07-27 16:00ETQuotes delayed by 15 min
331.89MMarket Cap
LossP/E TTM

LXEO Financials

See Lexeo Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Lexeo Therapeutics Inc Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
-0.25/-0.31
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.86
39.76%
Analyst Rating
STRONG BUY
2026/07/27
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Financial Indicators
EPS
74.77%-0.25
65.15%-0.27
62.71%-0.33
6.91%-0.60
-27.26%-0.99
-36.24%-0.78
-9.42%-0.89
-18.11%-0.64
-2.46%-0.77
2.67%-0.58
---0.82
---0.54
---0.76
---0.59
---1.81
----
----
Revenue
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00
--531.00K
--37.00K
--85.55K
Net Profit
38.16%-20.20M
19.31%-20.92M
31.22%-20.28M
-22.91%-26.10M
-50.61%-32.66M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
2.68%-14.19M
-17.90%-20.11M
11.24%-13.44M
-49.24%-18.66M
---14.58M
---17.05M
---15.14M
---12.50M
Net Margin
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---6834.86%
----
----
Gross Margin
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--100.00%
----
----
Debt to assets ratio
-70.10%0.29%
-66.68%0.31%
-17.87%0.71%
-25.93%0.62%
23.23%0.97%
-25.23%0.94%
-92.13%0.87%
-72.44%0.84%
-70.52%0.79%
--1.26%
--11.00%
--3.05%
--2.67%
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00
--531.00K
--37.00K
--85.55K
Operating profit
33.94%-22.33M
15.58%-23.12M
31.37%-21.65M
-30.31%-30.69M
-45.14%-33.80M
-82.86%-27.38M
-55.59%-31.54M
-68.52%-23.55M
-20.74%-23.29M
1.47%-14.97M
-15.96%-20.27M
8.73%-13.97M
-54.09%-19.29M
---15.20M
---17.48M
---15.31M
---12.52M
Net Profit
38.16%-20.20M
19.31%-20.92M
31.22%-20.28M
-22.91%-26.10M
-50.61%-32.66M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
2.68%-14.19M
-17.90%-20.11M
11.24%-13.44M
-49.24%-18.66M
---14.58M
---17.05M
---15.14M
---12.50M
Current assets
90.80%200.86M
49.37%188.39M
-19.86%127.79M
-20.94%140.06M
-46.86%105.27M
1.47%126.12M
310.19%159.46M
263.67%177.15M
223.56%198.09M
--124.29M
--38.87M
--48.71M
--61.22M
----
----
----
----
Total current liabilities
-53.97%14.19M
-26.43%16.81M
-35.60%17.27M
67.36%31.59M
42.50%30.82M
32.53%22.85M
16.42%26.82M
38.19%18.88M
57.95%21.63M
--17.24M
--23.04M
--13.66M
--13.69M
----
----
----
----
Total assets
99.19%250.36M
82.85%268.69M
-17.27%143.84M
-8.30%176.07M
-41.05%125.69M
5.10%146.94M
217.71%173.87M
195.67%192.01M
173.96%213.21M
--139.81M
--54.72M
--64.94M
--77.82M
----
----
----
----
Total liabilities
-49.81%18.86M
-26.85%22.02M
-33.37%23.01M
39.88%37.85M
24.19%37.58M
14.57%30.10M
6.28%34.54M
15.02%27.06M
26.21%30.25M
--26.27M
--32.50M
--23.52M
--23.97M
----
----
----
----
Total equity
162.72%231.50M
111.11%246.67M
-13.27%120.83M
-16.21%138.22M
-51.84%88.11M
2.91%116.84M
526.89%139.33M
298.29%164.95M
239.73%182.95M
--113.53M
--22.23M
--41.41M
--53.85M
----
----
----
----
Net operating income
2.63%-21.14M
29.11%-20.08M
-65.94%-29.55M
-35.07%-27.22M
-46.07%-21.72M
-102.60%-28.33M
-27.65%-17.81M
-52.77%-20.15M
19.09%-14.87M
15.91%-13.98M
-18.32%-13.95M
-19.37%-13.19M
-21.73%-18.38M
---16.63M
---11.79M
---11.05M
---15.09M
Net investment
76.03%27.46M
-8.66%-101.69M
42281.93%35.01M
-17869.72%-39.17M
8182.90%15.60M
-128095.89%-93.58M
-56.60%-83.00K
-458.97%-218.00K
---193.00K
31.78%-73.00K
86.75%-53.00K
82.30%-39.00K
100.00%0.00
---107.00K
---400.00K
---220.38K
---173.63K
Net financing
22190.91%2.45M
148318.56%143.77M
172.22%52.00K
24972.16%72.96M
-99.99%11.00K
-100.10%-97.00K
-101.84%-72.00K
407.74%291.00K
91083.17%88.65M
123644.44%100.07M
11277.14%3.91M
-292.93%-94.56K
-138.06%-97.44K
---81.00K
---35.00K
--49.01K
--255.99K

FAQs

What are the current assets of Lexeo Therapeutics Inc?

According to Lexeo Therapeutics Inc's FY2025 earnings report, its current assets were 188.39M, with a year-on-year change of 49.37.

What are the total assets of Lexeo Therapeutics Inc?

According to Lexeo Therapeutics Inc's FY2025 earnings report, its total assets of Lexeo Therapeutics Inc were 268.69M, with a year-on-year change of 82.85.

What are the total liabilities of Lexeo Therapeutics Inc?

According to Lexeo Therapeutics Inc's FY2025 earnings report, its total liabilities of Lexeo Therapeutics Inc were 22.02M, with a year-on-year change of -26.85.

What is the total equity of Lexeo Therapeutics Inc?

According to Lexeo Therapeutics Inc's FY2025 earnings report, its total equity of Lexeo Therapeutics Inc was 246.67M, with a year-on-year change of 111.11.

What is the net operating income of Lexeo Therapeutics Inc?

According to Lexeo Therapeutics Inc's FY2025 earnings report, its net operating income of Lexeo Therapeutics Inc was -109.26M, with a year-on-year change of -3.30.

What is the net investment of Lexeo Therapeutics Inc?

According to Lexeo Therapeutics Inc's FY2025 earnings report, its net investment of Lexeo Therapeutics Inc was -90.25M, with a year-on-year change of 4.07.

What is the net financing of Lexeo Therapeutics Inc?

According to Lexeo Therapeutics Inc's FY2025 earnings report, its net financing of Lexeo Therapeutics Inc was 216.79M, with a year-on-year change of 144.20.

What is the Earnings Per Share (EPS) of Lexeo Therapeutics Inc?

According to Lexeo Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.86, with a year-on-year change of 39.76.

What is the net income of Lexeo Therapeutics Inc?

According to Lexeo Therapeutics Inc's FY2025 earnings report, its net income was -99.96M, with a year-on-year change of -1.66.

What is the debt-to-asset ratio of Lexeo Therapeutics Inc?

According to Lexeo Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 0.31, with a year-on-year change of -66.68.

What is the Return on Equity (ROE) of Lexeo Therapeutics Inc?

According to Lexeo Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -55.00, with a year-on-year change of 35.58.

What is the Return on Assets (ROA) of Lexeo Therapeutics Inc?

According to Lexeo Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -48.10, with a year-on-year change of 29.87.

What is the operating profit of Lexeo Therapeutics Inc?

According to Lexeo Therapeutics Inc's FY2025 earnings report, its operating profit was -109.26M, with a year-on-year change of -3.30.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.